Taspoglutide clinical trials antidiabetic drugs

taspoglutide

Acute myocardial infarction

1 trials  - HEBE III

Diabetes type 2

All type of patients:  14 trials  - Ratner (20mg once weekly) - Nauck 10 once weekly vs PBO - Nauck 20 every 2 weeks vs PBO - Nauck 20 once weekly vs PBO - BC20750 - BC20963 - BC20965 - BC21625 - BC21713 (vs placebo) - BC21893 - BC22092 - BP21572 - NC25113 - ZC22565

Patients inadequately controlled on MET+SU therapy :  3 trials  - BC20965 - BC21893 - ZC22565

Patients inadequately controlled on metformin:  4 trials  - Ratner (20mg once weekly) - Nauck 10 once weekly vs PBO - BC21713 (vs placebo) - BC22092

Patients inadequately controlled on monotherapy :  4 trials  - Ratner (20mg once weekly) - Nauck 10 once weekly vs PBO - BC21713 (vs placebo) - BC22092

Patients inadequately controlled with insulin:  2 trials  - BC20965 - ZC22565

Patients with insufficient glycaemic control with bitherapy:  5 trials  - BC20963 - BC20965 - BC21625 - BC21893 - ZC22565

Heart failure

6 trials  - Parissis - Kourea - Parissis - STAMINA-HeFT (Ghali) - Ponikowski - van Veldhuisen